Company profile
Genix Pharmaceuticals Corporation
OTC: GENPF · Healthcare · Drug Manufacturers - Specialty & Generic
Canadian filerHQ Vancouver, BCReports USD
#1166 of 1,422 Healthcare companies by revenuebottom-decile growth
EA Score
——FH 5DQ —GM —SS 51
v0.1 · 35/100 weight · pillars only
↑ workforce scale, disclosure history · ↓ revenue growth (YoY), Piotroski F
Methodology →Revenue TTM
$0
Rev growth YoY (TTM)
-100.0%
Net income (FY)
-$239.2k
Employees
4,000
as of 2026-08-26
Market cap
$844.9k
as of 2026-08-26
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$00 CAD2025
Net income-$239.2k-335.0k CAD2025
Operating income-$109.4k-153.3k CAD2025
Total assets$36.4k51.0k CAD2025
Liabilities$1.0M1.5M CAD2025
Equity-$1.0M-1.4M CAD2025
Revenue trend
FY2018 – FY2025 · USD
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Genix Pharmaceuticals Corporation’s revenue?
Genix Pharmaceuticals Corporation booked $0 in FY2025 revenue, contracting 100% year over year — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.
Peers · Healthcare
The Cannaisseur Group, Inc.8DOdyssey Health, Inc.21DAvalon GloboCare Corp.35DPharmadrug Inc.——Agentix Corp.17DNKGen Biotech, Inc.——Key facts
CEOSina Salehi Pirooz
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersVancouver, BC
ExchangeOTC: GENPF
Employees4,000
IPO date2020-02-18
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.